News & Updates
Filter by Specialty:
Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
05 Jan 2023
byRoshini Claire Anthony
Young breast cancer survivors could safely temporarily stop adjuvant endocrine therapy (ET) to attempt pregnancy, according to primary results of the POSITIVE* trial presented at SABCS 2022.
Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
05 Jan 2023
Assisted reproductive technology poses no excess risk of multiple sclerosis
01 Jan 2023
Exposure to assisted reproductive technology (ART) does not appear to promote the development of multiple sclerosis, a study has found.
Assisted reproductive technology poses no excess risk of multiple sclerosis
01 Jan 2023
Updated monarchE results show improved treatment effects of abemaciclib for breast cancer
28 Dec 2022
byAudrey Abella
In the preplanned overall survival (OS) interim analysis of the monarchE study, the combination of abemaciclib and endocrine therapy (ET) continued to provide benefit for individuals with HR+, HER2–, node-positive, high-risk early breast cancer even after completion of therapy.
